arrow
Y

Yogen Saunthararajah

cleveland clinic
H指数:52
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

H2BE113K mutation promotes breast cancer metastasis through modulating chromatin dynamics

H2BE113K突变通过调控染色质动力学促进乳腺癌转移

2026-07-100
OA
Metronomic low-dose regimen of decitabine and venetoclax is safe and reduces monocyte burden in chronic myelomonocytic leukemia

去甲基化药物地西他滨与维奈克拉低剂量密集联合方案安全且可减轻慢性髓单核细胞白血病的单核细胞负荷

2026-01-010
PRE
SMARCA5 AS A THERAPEUTIC TARGET FOR GLIOBLASTOMA

SMARCA5 作为治疗胶质母细胞瘤的靶点

2025-11-010
OAAI
Combining drugs that bypass p53 to treat TP53-mutated leukemias

联合使用可绕过p53的药物以治疗TP53突变的白血病

2025-10-100
OAAI
PET imaging of hepatocellular carcinoma with [124I]IV-14

[124I]IV-14 PET成像在肝细胞癌中的应用

2025-04-071
OA
Eltrombopag inhibits TET dioxygenase to contribute to hematopoietic stem cell expansion in aplastic anemia

艾曲波帕抑制TET双加氧酶促进再生障碍性贫血造血干细胞扩增

2022-02-1517
OAAI
Functional characterization of NPM1-TYK2 fusion oncogene
2022-01-188
OAAI
Single cell RNA sequencing of AML initiating cells reveals RNA-based evolution during disease progression
LEUKEMIA
IF13.4
2021-07-0950
OAAI
Thioredoxin reductase is a major regulator of metabolism in leukemia cells
2021-07-0818
OAAI